Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization - Trial NCT06102720
Access comprehensive clinical trial information for NCT06102720 through Pure Global AI's free database. This Phase 4 trial is sponsored by Mikhail Zykov and is currently Recruiting. The study focuses on Ischemic Stroke. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Mikhail Zykov
Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Timeline & Enrollment
Phase 4
Jan 12, 2023
Feb 01, 2025
Primary Outcome
Any new stroke events,Neurological deterioration
Summary
This study is two-center, prospective, randomized, open-label, controlled,
 investigator-sponsored study that aims to investigate the efficacy of low-dose colchicine in
 preventing recurrent stroke in the patients with acute atherothrombotic minor-to-moderate
 ischemic stroke during hospitalization.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06102720
Non-Device Trial